SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001601485-24-000017
Filing Date
2024-03-29
Accepted
2024-03-28 18:15:20
Documents
1
Effectiveness Date
2024-03-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12736
  Complete submission text file 0001601485-24-000017.txt   13979
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509031 | Film No.: 24801054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)